Last reviewed · How we verify
NCT05970588
Standing Desk Converter & Habitual Posture
NA trial testing Standing Promotion Intervention in Sedentary Time in 50 participants. Currently enrolling.
1 September 2025
Quick facts
| Lead sponsor | Olga Theou |
|---|---|
| Phase | NA |
| Status | Recruiting now |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | other |
| Enrollment | 50 |
| Start date | 1 October 2023 |
| Primary completion | 1 September 2025 |
| Estimated completion | 1 September 2025 |
| Sites | 1 location across Canada |
Drugs / interventions tested
- Standing Promotion Intervention
Conditions studied
- Sedentary Time — all drugs for Sedentary Time →
- Cognitive Function — all drugs for Cognitive Function →
- Blood Pressure Regulation — all drugs for Blood Pressure Regulation →
Sponsor
Olga Theou
Who can join
18 and older, any sex, with Sedentary Time or Cognitive Function. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This project will determine the short-term impact of a standing desk converter on: 1) objectively measured physical activity and posture levels, and 2) brain (cognition) and heart (blood pressure regulation) function. The main outcome is habitual activity patterns, assessed by the thigh-worn inclinometer (activPAL). All participants will be equipped with an activPAL and have their cardiovascular and cognitive function assessed at baseline and 4 weeks. Participants in the intervention group will use a standing desk converter for 4 weeks, while the wait-list control group will be encouraged to maintain their regular activity patterns. Researchers will compare the intervention and control groups to see if using the standing desk converter will increase standing time and lower sedentary time, improve cognition, and improve blood pressure regulation.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT05970588
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Sedentary Time
Currently open trials in the same condition.
- NCT06963736 — WatchWell: Simple and Practical Strategies to Reduce the Negative Health Impact of Sedentary Screen Time · NA · recruiting
- NCT05935241 — mPATH for Low-income Older Adults · NA · recruiting
- NCT05316571 — Sitting Interruption and Whole-body Cardiovascular Health · NA · recruiting
Other Olga Theou trials
Trials by the same sponsor.
- NCT03682523 — The Breaking "Bad Rest" Study: Interrupting Sedentary Time to Reverse Frailty Levels in Acute Care · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05970588 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Olga Theou
- Last refreshed: 1 October 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05970588.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing